Balyasny Asset Management’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.44M Sell
5,522,769
-175
-0% -$358 0.01% 1110
2026
Q2
$13.5M Buy
5,522,944
+505,211
+10% +$1.15M 0.02% 923
2026
Q1
$11.3M Buy
+5,017,733
New +$10.6M 0.01% 979

Other funds holding IPSC

Balyasny Asset Management's IPSC Position: Q3 2026 in Review

Balyasny Asset Management reduced its Century Therapeutics (IPSC) stake by 0% in Q3 2026, selling an estimated $358 and leaving 5,522,769 shares worth $9.44M. The position accounts for 0.01% of the portfolio, ranked #1110.

Balyasny Asset Management first reported a position in IPSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.5M in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Balyasny Asset Management held 5,522,769 shares of Century Therapeutics worth $9.44M as of Q3 2026.
  • Balyasny Asset Management sold 175 Century Therapeutics shares in Q3 2026, an estimated $358.
  • Century Therapeutics made up 0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #1110 holding.
  • Balyasny Asset Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Balyasny Asset Management's Century Therapeutics position peaked at $13.5M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.